Trials / Unknown
UnknownNCT04977544
Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder
A Randomized Controlled Study of Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To explore the efficacy of drugs combined with virtual reality exposure therapy in the treatment of phobias compared with single drug treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | vert | On the basis of sertraline drug treatment, phobia patients were given 2d/times from the 5th week, each 35-45min VR exposure treatment, 15 times as a course of treatment. |
| DRUG | Sertraline | Sertraline was given as a single drug, with an initial dose of 50 mg/d, and gradually increased to the maximum dose of 200 mg/d after 2 weeks. The treating physician will determine the specific dose adjustment according to the patient's condition. |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-07-27
- Last updated
- 2021-07-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04977544. Inclusion in this directory is not an endorsement.